Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Feng Y, Broder CC, Kennedy PE, Berger EA.

Science. 1996 May 10;272(5263):872-7.

PMID:
8629022
2.

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA.

Science. 1996 Jun 28;272(5270):1955-8.

PMID:
8658171
3.

Identification of a major co-receptor for primary isolates of HIV-1.

Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR.

Nature. 1996 Jun 20;381(6584):661-6.

PMID:
8649511
5.
6.

CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry.

Tachibana K, Nakajima T, Sato A, Igarashi K, Shida H, Iizasa H, Yoshida N, Yoshie O, Kishimoto T, Nagasawa T.

J Exp Med. 1997 May 19;185(10):1865-70.

7.

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B.

Nature. 1996 Aug 29;382(6594):833-5. Erratum in: Nature 1996 Nov 21;384(6606):288.

PMID:
8752281
8.

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.

Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA.

Nature. 1996 Aug 29;382(6594):829-33.

PMID:
8752280
9.

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.

Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H.

Science. 1996 Oct 25;274(5287):602-5.

PMID:
8849450
10.

Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection.

Baiocchi M, Olivetta E, Chelucci C, Santarcangelo AC, Bona R, d'Aloja P, Testa U, Komatsu N, Verani P, Federico M.

Blood. 1997 Apr 15;89(8):2670-8.

11.
12.

Co-receptors for HIV-1 entry.

Moore JP, Trkola A, Dragic T.

Curr Opin Immunol. 1997 Aug;9(4):551-62. Review.

PMID:
9287172
13.

Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

Litwin V, Nagashima KA, Ryder AM, Chang CH, Carver JM, Olson WC, Alizon M, Hasel KW, Maddon PJ, Allaway GP.

J Virol. 1996 Sep;70(9):6437-41.

14.

Likely HIV cofactor found.

Cohen J.

Science. 1996 May 10;272(5263):809-10. No abstract available.

PMID:
8629006
15.

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW.

Cell. 1996 Jun 28;85(7):1149-58.

16.

CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons.

Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL, Taub D, Horuk R.

Curr Biol. 1997 Feb 1;7(2):112-21.

17.

Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.

Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, Clapham PR.

J Virol. 1997 Sep;71(9):6407-15.

18.
19.

Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.

Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, Littman DR, Lapham CK.

J Virol. 1995 Oct;69(10):6140-8.

20.

Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies.

Hori T, Sakaida H, Sato A, Nakajima T, Shida H, Yoshie O, Uchiyama T.

J Immunol. 1998 Jan 1;160(1):180-8. Erratum in: J Immunol 1999 Jul 15;163(2):1092.

Supplemental Content

Support Center